Literature DB >> 465890

Single pulse stimulation of guinea-pig vas deferens and the presynaptic receptor hypothesis.

S Kalsner.   

Abstract

1 The effect of phenoxybenzamine on the efflux of [3H]-noradrenaline and the mechanical response to single pulse excitation of superfused guinea-pig vas deferens was determined to examine the validity of the currently accepted hypothesis of a presynaptic negative feedback system on adrenergic nerve terminals. 2 The adrenoceptor antagonist enhanced both the outflow of tritium and the mechanical response to single pulse stimulation. The efflux of labelled material and the responses to 4 pulses were also enhanced, as expected. 3 Blockade of neuronal and extraneuronal uptake did not by itself increase nerve-induced outflow or the mechanical response nor dated within the framework of a hypothesis that proposes that the enhancement of response and tritium efflux by phenoxybenzamine results from blockade of a feedback system whereby noradrenaline released by previous impulses inhibits its own subsequent release.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 465890      PMCID: PMC2043637          DOI: 10.1111/j.1476-5381.1979.tb13686.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  30 in total

1.  EFFECT OF COCAINE, PHENOXYBENZAMINE AND PHENTOLAMINE ON THE CATECHOLAMINE OUTPUT FROM SPLEEN AND ADRENAL MEDULLA.

Authors:  S M KIRPEKAR; P CERVONI
Journal:  J Pharmacol Exp Ther       Date:  1963-10       Impact factor: 4.030

2.  The effect of stimulus intensity on alpha-adrenoceptor-mediated feedback control of noradrenaline release.

Authors:  B Harper; I E Hughes
Journal:  Br J Pharmacol       Date:  1978-08       Impact factor: 8.739

3.  Calcium movements during the release of catecholamines from the adrenal medulla: effects of methoxyverapamil and external cations.

Authors:  J Aguirre; J E Pinto; J M Trifaró
Journal:  J Physiol       Date:  1977-07       Impact factor: 5.182

4.  Physiological significance of alpha-adrenoceptor-mediated negative feedback mechanism regulating noradrenaline release during nerve stimulation.

Authors:  S Z Langer; E Adler-Graschinsky; O Giorgi
Journal:  Nature       Date:  1977-02-17       Impact factor: 49.962

Review 5.  Presynaptic alpha-adrenoceptors.

Authors:  K Starke; T Endo
Journal:  Gen Pharmacol       Date:  1976-10

6.  The effect of different calcium concentrations on the inhibitory effect of presynaptic alpha-adrenoceptors in the rat vas deferens.

Authors:  G M Drew
Journal:  Br J Pharmacol       Date:  1978-07       Impact factor: 8.739

Review 7.  Sixth gaddum memorial lecture, National Institute for Medical Research, Mill Hill, January 1977. Presynaptic receptors and their role in the regulation of transmitter release.

Authors:  S Z Langer
Journal:  Br J Pharmacol       Date:  1977-08       Impact factor: 8.739

8.  The effects of release and depletion of endogenous noradrenaline on the transmission of impulses in the mouse vas deferens.

Authors:  I Marshall; P A Nasmyth; N B Shepperson
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

9.  The effects of piperoxan on uptake of noradrenaline and overflow of transmitter in the isolated blood perfused spleen of the cat.

Authors:  A G Blakeley; R J Summers
Journal:  Br J Pharmacol       Date:  1978-08       Impact factor: 8.739

10.  THE EFFECT OF PHENOXYBENZAMINE AND OF TOLAZOLINE ON THE RESPONSE TO SYMPATHETIC STIMULATION.

Authors:  J H BURN; W R GIBBONS
Journal:  Br J Pharmacol Chemother       Date:  1964-06
View more
  22 in total

1.  Only activated but not non-activated presynaptic alpha 2-autoreceptors interfere with neighbouring presynaptic receptor mechanisms.

Authors:  N Limberger; E A Singer; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-07       Impact factor: 3.000

2.  Transmitter release patterns of noradrenergic, dopaminergic and cholinergic axons in rabbit brain slices during short pulse trains, and the operation of presynaptic autoreceptors.

Authors:  A Mayer; N Limberger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-12       Impact factor: 3.000

3.  Evidence for autoinhibition of stimulation-induced noradrenaline release from vasa deferentia of the guinea-pig and rat.

Authors:  M W McCulloch; M Papanicolaou; M J Rand
Journal:  Br J Pharmacol       Date:  1985-10       Impact factor: 8.739

4.  The physiological and pharmacological role of presynaptic alpha- and beta-adrenoceptors in man.

Authors:  M J Brown; A D Struthers; J M Burrin; L Di Silvio; D C Brown
Journal:  Br J Clin Pharmacol       Date:  1985-12       Impact factor: 4.335

5.  Evidence against the unitary hypothesis of agonist and antagonist action at presynaptic adrenoceptors.

Authors:  S Kalsner
Journal:  Br J Pharmacol       Date:  1982-10       Impact factor: 8.739

6.  The role of calcium in the effects of noradrenaline and phenoxybenzamine on adrenergic transmitter release from atria: no support for negative feedback of release.

Authors:  S Kalsner
Journal:  Br J Pharmacol       Date:  1981-06       Impact factor: 8.739

7.  Stimulation-evoked release of [3H]-noradrenaline by 1, 10 or 100 pulses and its modification through presynaptic alpha 2-adrenoceptors.

Authors:  I Marshall
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

8.  Interactions between the effects of yohimbine, clonidine and [Ca]o on the electrical response of the mouse vas deferens.

Authors:  A G Blakeley; A Mathie; S A Petersen
Journal:  Br J Pharmacol       Date:  1986-08       Impact factor: 8.739

9.  Further study of prerequisites for the enhancement by alpha-adrenoceptor antagonists of the release of noradrenaline.

Authors:  N Limberger; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-03       Impact factor: 3.000

10.  Yohimbine and prolongation of stimulation pulse duration alter similarly 3H-transmitter efflux in heart: an alternative to the negative feedback hypothesis.

Authors:  S Kalsner
Journal:  Br J Pharmacol       Date:  1983-08       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.